A bill for an act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for public employees.

This bill requires Iowa's Department of Health and Human Services (HHS) and Department of Administrative Services (DAS) to review anti-obesity medications - including GLP-1 agonists - for use in the state's medical assistance program (Medicaid) and public employee health insurance plans. The review will assess the drugs' effectiveness for weight loss, impact on related health conditions, potential cost savings, and eligibility requirements. HHS and DAS must submit a report with findings and recommendations to the legislature by January 5, 2026. The review aims to inform future coverage decisions for Medicaid recipients and public employees, without immediately changing current policies.